The Qstent, a novel non-DES coronary stent shows fast endothelialization while maintaining low neointimal hyperplasia in pig study
Qvanteq has developed a simple and cost effective method to modify the surface of any BMS. The novel technology results in a durable and highly hydrophilic stent surface. The Qstent shows favorable endothelialization and thrombogenicity properties.
The Qstent is a valuable alternative to DES due to its significantly reduced neointimal hyperplasia compared to BMS. Its fast and complete endothelialization promises minimum anti-platelet treatment time (comparable to BMS) and can present a clear advantage over currently used DES.